Paragon 28, Inc. (FNA)

Apr 21, 2025 - FNA was delisted (reason: acquired by ZBH)
13.09
0.00 (0.00%)
Inactive · Last trade price on Apr 17, 2025
Market Cap 1.10B
Revenue (ttm) 256.18M
Net Income (ttm) -54.64M
Shares Out 83.89M
EPS (ttm) -0.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 16,574,214
Open 13.01
Previous Close 13.09
Day's Range 13.07 - 13.11
52-Week Range 4.65 - 13.13
Beta 1.47
Analysts Hold
Price Target 14.50 (+10.77%)
Earnings Date May 7, 2025

About FNA

Paragon 28, Inc. develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. The company offers forefoot systems, including gorilla precision MTP plating system, gorilla precision lapidus plating system, phantom lapidus intramedullary nail system, Bun-Yo-Matic lapidus clamp, and precision MIS screw system; and fracture fixation systems comprising gorilla ankle fracture plating system, baby gorilla plating system, monster screw system, monkey bars external fixation system, R3Flex syndesmotic repair ... [Read more]

Industry Medical Devices
Sector Healthcare
IPO Date Oct 15, 2021
Employees 525
Stock Exchange NYSE
Ticker Symbol FNA
Full Company Profile

Financial Performance

In 2024, Paragon 28's revenue was $256.18 million, an increase of 18.39% compared to the previous year's $216.39 million. Losses were -$54.64 million, -5.03% less than in 2023.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for FNA stock is "Hold." The 12-month stock price forecast is $14.5, which is an increase of 10.77% from the latest price.

Price Target
$14.5
(10.77% upside)
Analyst Consensus: Hold
Stock Forecasts

News

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Shareholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / April 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

1 day ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Investors to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / April 24, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

6 days ago - Accesswire

Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / April 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

8 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Investors to Connect

NEW YORK CITY, NY / ACCESS Newswire / April 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

10 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Stockholders to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / April 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

13 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Investors to Inquire about Securities Investigation

NEW YORK CITY, NY / ACCESS Newswire / April 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

15 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Investors to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / April 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

17 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Paragon 28, Inc. (FNA) And Encourages Stockholders to Reach Out

NEW YORK CITY, NY / ACCESS Newswire / April 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") ...

20 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Stockholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / April 8, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (...

22 days ago - Accesswire

Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

NEW YORK CITY, NY / ACCESS Newswire / April 6, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (...

24 days ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Shareholders to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / April 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:...

27 days ago - Accesswire

PARAGON 28 INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Paragon 28, Inc. - FNA

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Paragon 28, Inc....

Other symbols: ZBH
4 weeks ago - Business Wire

Paragon 28, Inc. (FNA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / April 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Encourages Paragon 28, Inc. (FNA) Shareholders to Inquire about Securities Investigation

NEW YORK, NY / ACCESS Newswire / March 30, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE...

4 weeks ago - Accesswire

Bronstein, Gewirtz & Grossman, LLC Is Investigating Paragon 28, Inc. (FNA) And Encourages Shareholders to Connect

NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE...

4 weeks ago - Accesswire

PARAGON 28 STOCKHOLDER NOTICE: Kaskela Law LLC Announces Investigation of Paragon 28, Inc. (NYSE: FNA) Proposed Stockholder Buyout and Encourages Investors to Contact the Firm for Additional Information

PHILADELPHIA, March 25, 2025 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Paragon 28, Inc. (“Paragon”) (NYSE: FNA) s...

5 weeks ago - GlobeNewsWire

Paragon 28 to Showcase Recent Product Launches at The American College of Foot and Ankle Surgeons Annual Conference

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation ...

5 weeks ago - Business Wire

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Paragon 28, Inc. (FNA) and Encourages Stockholders to Learn More About the Investigation

NEW YORK, NY / ACCESS Newswire / March 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE...

6 weeks ago - Accesswire

Paragon 28 Announces Expiration of HSR Act Waiting Period for Pending Acquisition by Zimmer Biomet Under HSR Act

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announc...

Other symbols: ZBH
7 weeks ago - Business Wire

Paragon 28 to Feature Several Recent Product Launches at The American Academy of Orthopaedic Surgeons Annual Conference

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, is pleased to announce its participation ...

7 weeks ago - Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA and TGI on Behalf of Shareholders

NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and...

Other symbols: TGI
2 months ago - Accesswire

Zimmer Biomet Announces Fourth Quarter and Full-Year 2024 Financial Results

Fourth quarter net sales of $2.023 billion increased 4.3% and 4.9% on a constant currency1 basis Fourth quarter diluted earnings per share were $1.20; adjusted1 diluted earnings per share were $2.31 F...

2 months ago - PRNewsWire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Paragon 28, Inc.

NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Paragon 28, Inc. (NYSE: FNA) and its board of directors concerning the proposed acquisi...

Other symbols: ZBH
3 months ago - PRNewsWire

Zimmer Biomet to buy Paragon 28 for $1.1 billion

Zimmer Biomet said on Tuesday it would acquire medical device company Paragon 28 for about $1.1 billion.

Other symbols: ZBH
3 months ago - Reuters

Zimmer Biomet Announces Definitive Agreement to Acquire Paragon 28

Demonstrates Zimmer Biomet's Commitment to Investing in Higher GrowthEnd-Markets, with Expansion into ~$5 Billion Foot and Ankle Segment Expected to Enhance Zimmer Biomet's Financial Profile; Immediat...

3 months ago - PRNewsWire